Abstract

PurposeUrinary pH is an important factor linked to renal stone disease and a useful marker in the treatment of urolithiasis. Although the gold standard for measuring urinary pH utilizes a glass electrode and a pH meter, at present dipstick testing is largely used to estimate urinary pH. However, the accuracy and precision of this method may be insufficient for making clinical decisions in patients with lithiasis. The aim of this study is to describe a new device for urinary pH testing.MethodsThe device includes a pH sensor based on differential measurement of an ISFET-REFET pair. The drawbacks associated with this type of configuration, namely short lifetime and manual fabrication, have been overcome in the prototype. An automatic one point calibration is performed when turning on the system. Two buffer solutions were utilized to determine the intra- and inter-day precision of the device. The pH of 30 fresh human urine samples was measured using a pH-meter, a dipstick and the new electronic device.ResultsIn some cases, dipstick measurements differed from those of the pH meter by more than 0.40 units, a clinically relevant discrepancy, whereas none of the measurements made with the new electronic device differed from the results of the pH-meter by more than 0.1 pH units.ConclusionsThis new electronic device has the possibility to be used by stone-formers to control their urinary pH at home, increasing the tools available for stone prevention and prophylaxis.

Highlights

  • Urinary pH is an important factor linked to renal stone disease (Hess 2006)

  • In some cases, dipstick measurements differed from those of the pH meter by more than 0.40 units, a clinically relevant discrepancy, whereas none of the measurements made with the new electronic device differed from the results of the pH-meter by more than 0.1 pH units

  • This new electronic device has the possibility to be used by stone-formers to control their urinary pH at home, increasing the tools available for stone prevention and prophylaxis

Read more

Summary

Introduction

The formation of calcium oxalate crystals in urine takes place through heterogeneous nucleation processes (Grases et al 2012; Finlayson 1978). For this reason, the presence of solid preformed particles is an indispensable. Calcium oxalate monohydrate (COM) papillary calculi initiate their formation in injured papillary tissue, mainly through calcification of this tissue by hydroxyapatite. When these deposits grow and erode the epithelium covering the papillae, they come into contact with urine. Due to the permanent supersaturation of calcium oxalate in urine, and through heterogeneous nucleation, COM papillary calculi start to develop (Grases et al 2013)

Objectives
Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call